Proactiveinvestors USA & Canada ReNeuron Group PLC https://ca.proactiveinvestors.com Proactiveinvestors USA & Canada ReNeuron Group PLC RSS feed en Tue, 25 Feb 2020 07:40:57 -0500 http://blogs.law.harvard.edu/tech/rss Genera CMS action@proactiveinvestors.com (Proactiveinvestors) action@proactiveinvestors.com (Proactiveinvestors) ReNeuron's retinal treatment 'appears to have sustained long-term beneficial effect' https://ca.proactiveinvestors.com/companies/news/913627/reneuron-s-retinal-treatment--appears-to-have-sustained-long-term-beneficial-effect--913627.html Tue, 25 Feb 2020 09:47:00 -0500 https://ca.proactiveinvestors.com/companies/news/913627/reneuron-s-retinal-treatment--appears-to-have-sustained-long-term-beneficial-effect--913627.html ReNeuron encouraged by 12-month data from cell therapy for degenerative eye disease https://ca.proactiveinvestors.com/companies/news/913498/reneuron-encouraged-by-12-month-data-from-cell-therapy-for-degenerative-eye-disease-913498.html Mon, 24 Feb 2020 07:31:00 -0500 https://ca.proactiveinvestors.com/companies/news/913498/reneuron-encouraged-by-12-month-data-from-cell-therapy-for-degenerative-eye-disease-913498.html ReNeuron says positive clinical data from Phase 2a trial of its CTX stem cell therapy candidate published in peer-reviewed journal https://ca.proactiveinvestors.com/companies/news/913032/reneuron-says-positive-clinical-data-from-phase-2a-trial-of-its-ctx-stem-cell-therapy-candidate-published-in-peer-reviewed-journal-913032.html Mon, 17 Feb 2020 08:35:00 -0500 https://ca.proactiveinvestors.com/companies/news/913032/reneuron-says-positive-clinical-data-from-phase-2a-trial-of-its-ctx-stem-cell-therapy-candidate-published-in-peer-reviewed-journal-913032.html ReNeuron progresses as it gathers more data for developing treatments https://ca.proactiveinvestors.com/companies/news/219881/reneuron-progresses-as-it-gathers-more-data-for-developing-treatments-219881.html Mon, 17 Feb 2020 05:54:00 -0500 https://ca.proactiveinvestors.com/companies/news/219881/reneuron-progresses-as-it-gathers-more-data-for-developing-treatments-219881.html ReNeuron in active on-going talks for further potential out-licence deals https://ca.proactiveinvestors.com/companies/news/908738/reneuron-in-active-on-going-talks-for-further-potential-out-licence-deals-908738.html Mon, 09 Dec 2019 10:52:00 -0500 https://ca.proactiveinvestors.com/companies/news/908738/reneuron-in-active-on-going-talks-for-further-potential-out-licence-deals-908738.html Proactive news snapshot: ReNeuron, Metal Tiger, i3 Energy, Kodal Minerals … https://ca.proactiveinvestors.com/companies/news/908640/proactive-news-snapshot-reneuron-metal-tiger-i3-energy-kodal-minerals--908640.html Fri, 06 Dec 2019 15:30:00 -0500 https://ca.proactiveinvestors.com/companies/news/908640/proactive-news-snapshot-reneuron-metal-tiger-i3-energy-kodal-minerals--908640.html ReNeuron interims chart a period of significant progress; out-licence deal talks ongoing https://ca.proactiveinvestors.com/companies/news/908628/reneuron-interims-chart-a-period-of-significant-progress-out-licence-deal-talks-ongoing-908628.html Fri, 06 Dec 2019 10:55:00 -0500 https://ca.proactiveinvestors.com/companies/news/908628/reneuron-interims-chart-a-period-of-significant-progress-out-licence-deal-talks-ongoing-908628.html Proactive news snapshot: ReNeuron, EQTEC, ADM Energy, Midatech Pharma … https://ca.proactiveinvestors.com/companies/news/905436/proactive-news-snapshot-reneuron-eqtec-adm-energy-midatech-pharma--905436.html Wed, 23 Oct 2019 14:33:00 -0400 https://ca.proactiveinvestors.com/companies/news/905436/proactive-news-snapshot-reneuron-eqtec-adm-energy-midatech-pharma--905436.html ReNeuron to present data showing “significant advance” of CTX treatment https://ca.proactiveinvestors.com/companies/news/905406/reneuron-to-present-data-showing-significant-advance-of-ctx-treatment-905406.html Wed, 23 Oct 2019 06:40:00 -0400 https://ca.proactiveinvestors.com/companies/news/905406/reneuron-to-present-data-showing-significant-advance-of-ctx-treatment-905406.html ReNeuron cell-based treatment hailed by leading non-profit group funding research into treatments for retinal degenerative diseases https://ca.proactiveinvestors.com/companies/news/904720/reneuron-cell-based-treatment-hailed-by-leading-non-profit-group-funding-research-into-treatments-for-retinal-degenerative-diseases-904720.html Mon, 14 Oct 2019 06:56:00 -0400 https://ca.proactiveinvestors.com/companies/news/904720/reneuron-cell-based-treatment-hailed-by-leading-non-profit-group-funding-research-into-treatments-for-retinal-degenerative-diseases-904720.html ReNeuron hails "clear signal" from retinitis pigmentosa trials https://ca.proactiveinvestors.com/companies/news/903982/reneuron-hails--clear-signal--from-retinitis-pigmentosa-trials-903982.html Mon, 07 Oct 2019 15:00:00 -0400 https://ca.proactiveinvestors.com/companies/news/903982/reneuron-hails--clear-signal--from-retinitis-pigmentosa-trials-903982.html 'All systems go' for ReNeuron's retinitis pigmentosa programme as it looks to follow-up studies https://ca.proactiveinvestors.com/companies/news/904267/-all-systems-go--for-reneuron-s-retinitis-pigmentosa-programme-as-it-looks-to-follow-up-studies-904267.html Mon, 07 Oct 2019 11:19:00 -0400 https://ca.proactiveinvestors.com/companies/news/904267/-all-systems-go--for-reneuron-s-retinitis-pigmentosa-programme-as-it-looks-to-follow-up-studies-904267.html Proactive news snapshot: ReNeuron, Asiamet Resources, Base Resources... https://ca.proactiveinvestors.com/companies/news/901229/proactive-news-snapshot-reneuron-asiamet-resources-base-resources-901229.html Wed, 21 Aug 2019 12:30:00 -0400 https://ca.proactiveinvestors.com/companies/news/901229/proactive-news-snapshot-reneuron-asiamet-resources-base-resources-901229.html ReNeuron hails heavy hitting new appointments to scientific advisory board https://ca.proactiveinvestors.com/companies/news/901202/reneuron-hails-heavy-hitting-new-appointments-to-scientific-advisory-board-901202.html Wed, 21 Aug 2019 06:20:00 -0400 https://ca.proactiveinvestors.com/companies/news/901202/reneuron-hails-heavy-hitting-new-appointments-to-scientific-advisory-board-901202.html ReNeuron inks University of Cardiff collaboration https://ca.proactiveinvestors.com/companies/news/900715/reneuron-inks-university-of-cardiff-collaboration-900715.html Wed, 14 Aug 2019 06:36:00 -0400 https://ca.proactiveinvestors.com/companies/news/900715/reneuron-inks-university-of-cardiff-collaboration-900715.html ReNeuron granted international patents over cell technology https://ca.proactiveinvestors.com/companies/news/223953/reneuron-granted-international-patents-over-cell-technology-223953.html Tue, 16 Jul 2019 06:20:00 -0400 https://ca.proactiveinvestors.com/companies/news/223953/reneuron-granted-international-patents-over-cell-technology-223953.html ReNeuron creates role of business development and alliance director as deals pursued https://ca.proactiveinvestors.com/companies/news/223793/reneuron-creates-role-of-business-development-and-alliance-director-as-deals-pursued-223793.html Fri, 12 Jul 2019 14:10:00 -0400 https://ca.proactiveinvestors.com/companies/news/223793/reneuron-creates-role-of-business-development-and-alliance-director-as-deals-pursued-223793.html ReNeuron makes key business development hire as it looks to build on licensing deals https://ca.proactiveinvestors.com/companies/news/314075/reneuron-makes-key-business-development-hire-as-it-looks-to-build-on-licensing-deals-14075.html Fri, 12 Jul 2019 12:03:00 -0400 https://ca.proactiveinvestors.com/companies/news/314075/reneuron-makes-key-business-development-hire-as-it-looks-to-build-on-licensing-deals-14075.html ReNeuron enjoys “transformational” year; eye disease trial data due in October https://ca.proactiveinvestors.com/companies/news/223726/reneuron-enjoys-transformational-year-eye-disease-trial-data-due-in-october-223726.html Thu, 11 Jul 2019 07:18:00 -0400 https://ca.proactiveinvestors.com/companies/news/223726/reneuron-enjoys-transformational-year-eye-disease-trial-data-due-in-october-223726.html ReNeuron wins Breakthrough of the Year at 2019 Mediscience Awards https://ca.proactiveinvestors.com/companies/news/222146/reneuron-wins-breakthrough-of-the-year-at-2019-mediscience-awards-222146.html Fri, 14 Jun 2019 10:29:00 -0400 https://ca.proactiveinvestors.com/companies/news/222146/reneuron-wins-breakthrough-of-the-year-at-2019-mediscience-awards-222146.html ReNeuron Group Plc - Proactive One2One Investor Forum May 2019 https://ca.proactiveinvestors.com/companies/news/313483/reneuron-group-plc---proactive-one2one-investor-forum-may-2019-13483.html Fri, 24 May 2019 14:17:00 -0400 https://ca.proactiveinvestors.com/companies/news/313483/reneuron-group-plc---proactive-one2one-investor-forum-may-2019-13483.html ReNeuron Group encouraged by level of interest in its key programmes https://ca.proactiveinvestors.com/companies/news/313261/reneuron-group-encouraged-by-level-of-interest-in-its-key-programmes-13261.html Wed, 08 May 2019 15:02:00 -0400 https://ca.proactiveinvestors.com/companies/news/313261/reneuron-group-encouraged-by-level-of-interest-in-its-key-programmes-13261.html ReNeuron well funded for pivotal period clinically and commercially https://ca.proactiveinvestors.com/companies/news/219860/reneuron-well-funded-for-pivotal-period-clinically-and-commercially-219860.html Wed, 08 May 2019 07:08:00 -0400 https://ca.proactiveinvestors.com/companies/news/219860/reneuron-well-funded-for-pivotal-period-clinically-and-commercially-219860.html ReNeuron says eye disease patients see “sustained and further improvement” after cell treatment https://ca.proactiveinvestors.com/companies/news/219157/reneuron-says-eye-disease-patients-see-sustained-and-further-improvement-after-cell-treatment-219157.html Fri, 26 Apr 2019 14:07:00 -0400 https://ca.proactiveinvestors.com/companies/news/219157/reneuron-says-eye-disease-patients-see-sustained-and-further-improvement-after-cell-treatment-219157.html ReNeuron 'very encouraged' by positive retinitis pigmentosa study results https://ca.proactiveinvestors.com/companies/news/313119/reneuron--very-encouraged--by-positive-retinitis-pigmentosa-study-results-13119.html Fri, 26 Apr 2019 13:29:00 -0400 https://ca.proactiveinvestors.com/companies/news/313119/reneuron--very-encouraged--by-positive-retinitis-pigmentosa-study-results-13119.html ReNeuron primed for further progress https://ca.proactiveinvestors.com/companies/news/218786/ReNeuron-primed-for-further-progress--218786.html Wed, 17 Apr 2019 13:42:00 -0400 https://ca.proactiveinvestors.com/companies/news/218786/ReNeuron-primed-for-further-progress--218786.html ReNeuron Group agrees £80mln cell therapy licensing deal for China https://ca.proactiveinvestors.com/companies/news/312938/reneuron-group-agrees-80mln-cell-therapy-licensing-deal-for-china-12938.html Wed, 10 Apr 2019 08:40:00 -0400 https://ca.proactiveinvestors.com/companies/news/312938/reneuron-group-agrees-80mln-cell-therapy-licensing-deal-for-china-12938.html ReNeuron shares up 30% after it strikes deal worth up to £80mln with Chinese pharma https://ca.proactiveinvestors.com/companies/news/218229/reneuron-shares-up-30-after-it-strikes-deal-worth-up-to-80mln-with-chinese-pharma-218229.html Tue, 09 Apr 2019 14:45:00 -0400 https://ca.proactiveinvestors.com/companies/news/218229/reneuron-shares-up-30-after-it-strikes-deal-worth-up-to-80mln-with-chinese-pharma-218229.html ReNeuron eyes profits after sustained efficacy in blindness treatment https://ca.proactiveinvestors.com/companies/news/312873/reneuron-eyes-profits-after-sustained-efficacy-in-blindness-treatment-12873.html Thu, 04 Apr 2019 14:38:00 -0400 https://ca.proactiveinvestors.com/companies/news/312873/reneuron-eyes-profits-after-sustained-efficacy-in-blindness-treatment-12873.html ReNeuron provides further encouraging update for potential sight-saving treatment https://ca.proactiveinvestors.com/companies/news/217933/reneuron-provides-further-encouraging-update-for-potential-sight-saving-treatment-217933.html Thu, 04 Apr 2019 09:10:00 -0400 https://ca.proactiveinvestors.com/companies/news/217933/reneuron-provides-further-encouraging-update-for-potential-sight-saving-treatment-217933.html ReNeuron starts dosing second cohort in eye disease trial https://ca.proactiveinvestors.com/companies/news/216616/reneuron-starts-dosing-second-cohort-in-eye-disease-trial-216616.html Mon, 18 Mar 2019 07:55:00 -0400 https://ca.proactiveinvestors.com/companies/news/216616/reneuron-starts-dosing-second-cohort-in-eye-disease-trial-216616.html ReNeuron shares spike 20% after it provides encouraging update to Phase II eye disease trial https://ca.proactiveinvestors.com/companies/news/214931/reneuron-shares-spike-20-after-it-provides-encouraging-update-to-phase-ii-eye-disease-trial-214931.html Wed, 20 Feb 2019 12:52:00 -0500 https://ca.proactiveinvestors.com/companies/news/214931/reneuron-shares-spike-20-after-it-provides-encouraging-update-to-phase-ii-eye-disease-trial-214931.html ReNeuron provides encouraging update to phase II eye disease trial https://ca.proactiveinvestors.com/companies/news/312303/reneuron-provides-encouraging-update-to-phase-ii-eye-disease-trial-12303.html Wed, 20 Feb 2019 12:14:00 -0500 https://ca.proactiveinvestors.com/companies/news/312303/reneuron-provides-encouraging-update-to-phase-ii-eye-disease-trial-12303.html ReNeuron partner to unveil production scale-up data https://ca.proactiveinvestors.com/companies/news/213692/reneuron-partner-to-unveil-production-scale-up-data-213692.html Thu, 31 Jan 2019 08:00:00 -0500 https://ca.proactiveinvestors.com/companies/news/213692/reneuron-partner-to-unveil-production-scale-up-data-213692.html First person treated in ReNeuron’s mid-stage US stroke trial https://ca.proactiveinvestors.com/companies/news/213226/first-person-treated-in-reneurons-mid-stage-us-stroke-trial-213226.html Thu, 24 Jan 2019 12:00:00 -0500 https://ca.proactiveinvestors.com/companies/news/213226/first-person-treated-in-reneurons-mid-stage-us-stroke-trial-213226.html ReNeuron Group's phase IIb stroke trial kicks off with first patient treated https://ca.proactiveinvestors.com/companies/news/311973/reneuron-group-s-phase-iib-stroke-trial-kicks-off-with-first-patient-treated-11973.html Thu, 24 Jan 2019 11:23:00 -0500 https://ca.proactiveinvestors.com/companies/news/311973/reneuron-group-s-phase-iib-stroke-trial-kicks-off-with-first-patient-treated-11973.html ReNeuron seeing increased interest across its assets from potential licensee partners https://ca.proactiveinvestors.com/companies/news/311809/reneuron-seeing-increased-interest-across-its-assets-from-potential-licensee-partners-11809.html Fri, 11 Jan 2019 16:42:00 -0500 https://ca.proactiveinvestors.com/companies/news/311809/reneuron-seeing-increased-interest-across-its-assets-from-potential-licensee-partners-11809.html ReNeuron signs exosome collaboration deal with US biopharma https://ca.proactiveinvestors.com/companies/news/311703/reneuron-signs-exosome-collaboration-deal-with-us-biopharma-11703.html Fri, 04 Jan 2019 12:07:00 -0500 https://ca.proactiveinvestors.com/companies/news/311703/reneuron-signs-exosome-collaboration-deal-with-us-biopharma-11703.html ReNeuron signs exosome collaboration deal with US biopharma https://ca.proactiveinvestors.com/companies/news/211941/reneuron-signs-exosome-collaboration-deal-with-us-biopharma-211941.html Fri, 04 Jan 2019 09:15:00 -0500 https://ca.proactiveinvestors.com/companies/news/211941/reneuron-signs-exosome-collaboration-deal-with-us-biopharma-211941.html ReNeuron focus on new clinical trials https://ca.proactiveinvestors.com/companies/news/311662/reneuron-focus-on-new-clinical-trials-11662.html Wed, 19 Dec 2018 09:23:00 -0500 https://ca.proactiveinvestors.com/companies/news/311662/reneuron-focus-on-new-clinical-trials-11662.html ReNeuron primed for significant clinical progress https://ca.proactiveinvestors.com/companies/news/211207/reneuron-primed-for-significant-clinical-progress-211207.html Fri, 14 Dec 2018 12:40:00 -0500 https://ca.proactiveinvestors.com/companies/news/211207/reneuron-primed-for-significant-clinical-progress-211207.html ReNeuron’s CTX stem cell platform could be used to fight cancer https://ca.proactiveinvestors.com/companies/news/207345/reneurons-ctx-stem-cell-platform-could-be-used-to-fight-cancer-207345.html Thu, 18 Oct 2018 11:49:00 -0400 https://ca.proactiveinvestors.com/companies/news/207345/reneurons-ctx-stem-cell-platform-could-be-used-to-fight-cancer-207345.html Breakthrough to open up potential new revenue opportunities for Reneuron Plc https://ca.proactiveinvestors.com/companies/news/310907/breakthrough-to-open-up-potential-new-revenue-opportunities-for-reneuron-plc-10907.html Thu, 18 Oct 2018 10:26:00 -0400 https://ca.proactiveinvestors.com/companies/news/310907/breakthrough-to-open-up-potential-new-revenue-opportunities-for-reneuron-plc-10907.html ReNeuron to resume discussions with other potential suitors as US pharma group backs out https://ca.proactiveinvestors.com/companies/news/205202/reneuron-to-resume-discussions-with-other-potential-suitors-as-us-pharma-group-backs-out-205202.html Wed, 19 Sep 2018 07:09:00 -0400 https://ca.proactiveinvestors.com/companies/news/205202/reneuron-to-resume-discussions-with-other-potential-suitors-as-us-pharma-group-backs-out-205202.html 'All systems go' with ReNeuron Group Plc looking to treat first PISCES III patient shortly https://ca.proactiveinvestors.com/companies/news/310461/-all-systems-go-with-reneuron-group-plc-looking-to-treat-first-pisces-iii-patient-shortly-10461.html Thu, 13 Sep 2018 10:20:00 -0400 https://ca.proactiveinvestors.com/companies/news/310461/-all-systems-go-with-reneuron-group-plc-looking-to-treat-first-pisces-iii-patient-shortly-10461.html ReNeuron will begin clinical trial shortly; upbeat on potential deals https://ca.proactiveinvestors.com/companies/news/204711/reneuron-will-begin-clinical-trial-shortly-upbeat-on-potential-deals-204711.html Wed, 12 Sep 2018 12:58:00 -0400 https://ca.proactiveinvestors.com/companies/news/204711/reneuron-will-begin-clinical-trial-shortly-upbeat-on-potential-deals-204711.html ReNeuron Group well funded for the next phase of development https://ca.proactiveinvestors.com/companies/news/200654/reneuron-group-well-funded-for-the-next-phase-of-development-200654.html Thu, 12 Jul 2018 06:59:00 -0400 https://ca.proactiveinvestors.com/companies/news/200654/reneuron-group-well-funded-for-the-next-phase-of-development-200654.html ReNeuron stands to net an initial US$5mln as US company runs rule over its retinal stem cell technology https://ca.proactiveinvestors.com/companies/news/200555/reneuron-stands-to-net-an-initial-us5mln-as-us-company-runs-rule-over-its-retinal-stem-cell-technology-200555.html Wed, 11 Jul 2018 11:10:00 -0400 https://ca.proactiveinvestors.com/companies/news/200555/reneuron-stands-to-net-an-initial-us5mln-as-us-company-runs-rule-over-its-retinal-stem-cell-technology-200555.html ReNeuron signs retinal stem cell exclusivity agreement https://ca.proactiveinvestors.com/companies/news/309821/reneuron-signs-retinal-stem-cell-exclusivity-agreement-9821.html Wed, 11 Jul 2018 10:30:00 -0400 https://ca.proactiveinvestors.com/companies/news/309821/reneuron-signs-retinal-stem-cell-exclusivity-agreement-9821.html ReNeuron Group head of research to present encouraging early data on potential cancer treatment https://ca.proactiveinvestors.com/companies/news/196410/reneuron-group-head-of-research-to-present-encouraging-early-data-on-potential-cancer-treatment-196410.html Fri, 04 May 2018 11:05:00 -0400 https://ca.proactiveinvestors.com/companies/news/196410/reneuron-group-head-of-research-to-present-encouraging-early-data-on-potential-cancer-treatment-196410.html ReNeuron wins £1.5mln to fund further development of its hRPC cell therapy candidate https://ca.proactiveinvestors.com/companies/news/195332/reneuron-wins-15mln-to-fund-further-development-of-its-hrpc-cell-therapy-candidate-195332.html Thu, 19 Apr 2018 06:42:00 -0400 https://ca.proactiveinvestors.com/companies/news/195332/reneuron-wins-15mln-to-fund-further-development-of-its-hrpc-cell-therapy-candidate-195332.html ReNeuron appoints new chief medical officer based in recently established US office https://ca.proactiveinvestors.com/companies/news/194632/reneuron-appoints-new-chief-medical-officer-based-in-recently-established-us-office-194632.html Tue, 10 Apr 2018 12:33:00 -0400 https://ca.proactiveinvestors.com/companies/news/194632/reneuron-appoints-new-chief-medical-officer-based-in-recently-established-us-office-194632.html ReNeuron's Michael Hunt updates on product development https://ca.proactiveinvestors.com/companies/news/308948/reneuron-s-michael-hunt-updates-on-product-development-8948.html Mon, 26 Mar 2018 13:55:00 -0400 https://ca.proactiveinvestors.com/companies/news/308948/reneuron-s-michael-hunt-updates-on-product-development-8948.html ReNeuron increases number of clinical sites in its PISCES III study https://ca.proactiveinvestors.com/companies/news/193777/reneuron-increases-number-of-clinical-sites-in-its-pisces-iii-study-193777.html Mon, 26 Mar 2018 07:49:00 -0400 https://ca.proactiveinvestors.com/companies/news/193777/reneuron-increases-number-of-clinical-sites-in-its-pisces-iii-study-193777.html ReNeuron's CTX cells play a part in positive artificial nerve tissue study https://ca.proactiveinvestors.com/companies/news/191575/reneuron-s-ctx-cells-play-a-part-in-positive-artificial-nerve-tissue-study-191575.html Tue, 13 Feb 2018 14:10:00 -0500 https://ca.proactiveinvestors.com/companies/news/191575/reneuron-s-ctx-cells-play-a-part-in-positive-artificial-nerve-tissue-study-191575.html ReNeuron Group presents positive stroke data to US conference https://ca.proactiveinvestors.com/companies/news/190670/reneuron-group-presents-positive-stroke-data-to-us-conference-190670.html Fri, 26 Jan 2018 14:45:00 -0500 https://ca.proactiveinvestors.com/companies/news/190670/reneuron-group-presents-positive-stroke-data-to-us-conference-190670.html ReNeuron pleased to secure podium presentation for stroke data at US conference https://ca.proactiveinvestors.com/companies/news/308669/reneuron-pleased-to-secure-podium-presentation-for-stroke-data-at-us-conference-8669.html Fri, 26 Jan 2018 12:48:00 -0500 https://ca.proactiveinvestors.com/companies/news/308669/reneuron-pleased-to-secure-podium-presentation-for-stroke-data-at-us-conference-8669.html ReNeuron hopes share consolidation will improve the marketability and liquidity of the stock https://ca.proactiveinvestors.com/companies/news/189570/reneuron-hopes-share-consolidation-will-improve-the-marketability-and-liquidity-of-the-stock-189570.html Fri, 05 Jan 2018 07:39:00 -0500 https://ca.proactiveinvestors.com/companies/news/189570/reneuron-hopes-share-consolidation-will-improve-the-marketability-and-liquidity-of-the-stock-189570.html 'Lots to look forward to' as ReNeuron gets go-ahead for phase IIb stroke trial https://ca.proactiveinvestors.com/companies/news/308553/-lots-to-look-forward-to-as-reneuron-gets-go-ahead-for-phase-iib-stroke-trial-8553.html Mon, 18 Dec 2017 12:06:00 -0500 https://ca.proactiveinvestors.com/companies/news/308553/-lots-to-look-forward-to-as-reneuron-gets-go-ahead-for-phase-iib-stroke-trial-8553.html ReNeuron receives approval from US authorities to kick off phase IIb stroke trial https://ca.proactiveinvestors.com/companies/news/188779/reneuron-receives-approval-from-us-authorities-to-kick-off-phase-iib-stroke-trial-188779.html Thu, 14 Dec 2017 07:51:00 -0500 https://ca.proactiveinvestors.com/companies/news/188779/reneuron-receives-approval-from-us-authorities-to-kick-off-phase-iib-stroke-trial-188779.html ReNeuron establishes Boston office ahead of US clinical trials https://ca.proactiveinvestors.com/companies/news/188492/reneuron-establishes-boston-office-ahead-of-us-clinical-trials-188492.html Fri, 08 Dec 2017 07:23:00 -0500 https://ca.proactiveinvestors.com/companies/news/188492/reneuron-establishes-boston-office-ahead-of-us-clinical-trials-188492.html ReNeuron jumps at opening bell as it gets green light to begin second part of phase I/II eye disease trial https://ca.proactiveinvestors.com/companies/news/186931/reneuron-jumps-at-opening-bell-as-it-gets-green-light-to-begin-second-part-of-phase-iii-eye-disease-trial-186931.html Wed, 08 Nov 2017 08:06:00 -0500 https://ca.proactiveinvestors.com/companies/news/186931/reneuron-jumps-at-opening-bell-as-it-gets-green-light-to-begin-second-part-of-phase-iii-eye-disease-trial-186931.html ReNeuron making good progress with all of its key therapeutic programmes https://ca.proactiveinvestors.com/companies/news/186516/reneuron-making-good-progress-with-all-of-its-key-therapeutic-programmes-186516.html Tue, 31 Oct 2017 15:40:00 -0400 https://ca.proactiveinvestors.com/companies/news/186516/reneuron-making-good-progress-with-all-of-its-key-therapeutic-programmes-186516.html ReNeuron's Michael Hunt discusses very encouraging long-term stroke data https://ca.proactiveinvestors.com/companies/news/308308/reneuron-s-michael-hunt-discusses-very-encouraging-long-term-stroke-data-8308.html Tue, 31 Oct 2017 12:00:00 -0400 https://ca.proactiveinvestors.com/companies/news/308308/reneuron-s-michael-hunt-discusses-very-encouraging-long-term-stroke-data-8308.html ReNeuron boss “delighted” with long-term stroke data https://ca.proactiveinvestors.com/companies/news/186477/reneuron-boss-delighted-with-long-term-stroke-data-186477.html Tue, 31 Oct 2017 08:22:00 -0400 https://ca.proactiveinvestors.com/companies/news/186477/reneuron-boss-delighted-with-long-term-stroke-data-186477.html ReNeuron awarded new grant by Wales for exosome research https://ca.proactiveinvestors.com/companies/news/186329/reneuron-awarded-new-grant-by-wales-for-exosome-research-186329.html Fri, 27 Oct 2017 07:03:00 -0400 https://ca.proactiveinvestors.com/companies/news/186329/reneuron-awarded-new-grant-by-wales-for-exosome-research-186329.html ReNeuron presents more data on potential for its Exosome therapy as cancer treatment https://ca.proactiveinvestors.com/companies/news/185236/reneuron-presents-more-data-on-potential-for-its-exosome-therapy-as-cancer-treatment-185236.html Mon, 09 Oct 2017 06:36:00 -0400 https://ca.proactiveinvestors.com/companies/news/185236/reneuron-presents-more-data-on-potential-for-its-exosome-therapy-as-cancer-treatment-185236.html ReNeuron Group's therapeutic programme progressing to plan https://ca.proactiveinvestors.com/companies/news/183513/reneuron-group-s-therapeutic-programme-progressing-to-plan-183513.html Wed, 06 Sep 2017 07:15:00 -0400 https://ca.proactiveinvestors.com/companies/news/183513/reneuron-group-s-therapeutic-programme-progressing-to-plan-183513.html It's 'all systems go' as ReNeuron gears up for Phase III stroke disability study https://ca.proactiveinvestors.com/companies/news/307724/it-s-all-systems-go-as-reneuron-gears-up-for-phase-iii-stroke-disability-study-7724.html Thu, 29 Jun 2017 14:46:00 -0400 https://ca.proactiveinvestors.com/companies/news/307724/it-s-all-systems-go-as-reneuron-gears-up-for-phase-iii-stroke-disability-study-7724.html ReNeuron Group upbeat as it progresses on all stem cell fronts https://ca.proactiveinvestors.com/companies/news/180035/reneuron-group-upbeat-as-it-progresses-on-all-stem-cell-fronts-180035.html Thu, 29 Jun 2017 07:58:00 -0400 https://ca.proactiveinvestors.com/companies/news/180035/reneuron-group-upbeat-as-it-progresses-on-all-stem-cell-fronts-180035.html ReNeuron set the broaden scope of eye disease research after regulatory sign-off for frozen cell line https://ca.proactiveinvestors.com/companies/news/179431/reneuron-set-the-broaden-scope-of-eye-disease-research-after-regulatory-sign-off-for-frozen-cell-line-179431.html Mon, 19 Jun 2017 06:24:00 -0400 https://ca.proactiveinvestors.com/companies/news/179431/reneuron-set-the-broaden-scope-of-eye-disease-research-after-regulatory-sign-off-for-frozen-cell-line-179431.html ReNeuron 'greatly encouraged' by US regulator feedback on CTX cell therapy trial https://ca.proactiveinvestors.com/companies/news/307575/reneuron-greatly-encouraged-by-us-regulator-feedback-on-ctx-cell-therapy-trial-7575.html Mon, 05 Jun 2017 11:04:00 -0400 https://ca.proactiveinvestors.com/companies/news/307575/reneuron-greatly-encouraged-by-us-regulator-feedback-on-ctx-cell-therapy-trial-7575.html ReNeuron Group receives "favourable feedback" and advice on stroke treatment from US regulator https://ca.proactiveinvestors.com/companies/news/178761/reneuron-group-receives-favourable-feedback-and-advice-on-stroke-treatment-from-us-regulator-178761.html Mon, 05 Jun 2017 06:16:00 -0400 https://ca.proactiveinvestors.com/companies/news/178761/reneuron-group-receives-favourable-feedback-and-advice-on-stroke-treatment-from-us-regulator-178761.html ReNeuron's Michael Hunt on 'very significant' exosome therapy data https://ca.proactiveinvestors.com/companies/news/307494/reneuron-s-michael-hunt-on-very-significant-exosome-therapy-data-7494.html Fri, 19 May 2017 13:28:00 -0400 https://ca.proactiveinvestors.com/companies/news/307494/reneuron-s-michael-hunt-on-very-significant-exosome-therapy-data-7494.html ReNeuron posts 'very significant' exosome therapy data at Toronto conference https://ca.proactiveinvestors.com/companies/news/177985/reneuron-posts-very-significant-exosome-therapy-data-at-toronto-conference-177985.html Thu, 18 May 2017 08:04:00 -0400 https://ca.proactiveinvestors.com/companies/news/177985/reneuron-posts-very-significant-exosome-therapy-data-at-toronto-conference-177985.html ReNeuron CFO 'very pleased' to be awarded £1.8mln grant https://ca.proactiveinvestors.com/companies/news/307441/reneuron-cfo-very-pleased-to-be-awarded-18mln-grant-7441.html Thu, 11 May 2017 12:30:00 -0400 https://ca.proactiveinvestors.com/companies/news/307441/reneuron-cfo-very-pleased-to-be-awarded-18mln-grant-7441.html Reneuron awarded £1.8mln to upgrade Wales facility https://ca.proactiveinvestors.com/companies/news/177647/reneuron-awarded-18mln-to-upgrade-wales-facility-177647.html Thu, 11 May 2017 07:20:00 -0400 https://ca.proactiveinvestors.com/companies/news/177647/reneuron-awarded-18mln-to-upgrade-wales-facility-177647.html ReNeuron highlights exosome therapy progress at leading conference https://ca.proactiveinvestors.com/companies/news/177369/reneuron-highlights-exosome-therapy-progress-at-leading-conference-177369.html Fri, 05 May 2017 08:30:00 -0400 https://ca.proactiveinvestors.com/companies/news/177369/reneuron-highlights-exosome-therapy-progress-at-leading-conference-177369.html ReNeuron update outlines ambitious plans for stroke and ophthalmology programmes https://ca.proactiveinvestors.com/companies/news/176707/reneuron-update-outlines-ambitious-plans-for-stroke-and-ophthalmology-programmes-176707.html Fri, 21 Apr 2017 13:39:00 -0400 https://ca.proactiveinvestors.com/companies/news/176707/reneuron-update-outlines-ambitious-plans-for-stroke-and-ophthalmology-programmes-176707.html ReNeuron CFO 'pleased' with reformulation of degenerative diseases treatment https://ca.proactiveinvestors.com/companies/news/307316/reneuron-cfo-pleased-with-reformulation-of-degenerative-diseases-treatment-7316.html Fri, 21 Apr 2017 11:44:00 -0400 https://ca.proactiveinvestors.com/companies/news/307316/reneuron-cfo-pleased-with-reformulation-of-degenerative-diseases-treatment-7316.html ReNeuron makes a guest appearance on BBC2 https://ca.proactiveinvestors.com/companies/news/173181/reneuron-makes-a-guest-appearance-on-bbc2-173181.html Wed, 15 Feb 2017 07:57:00 -0500 https://ca.proactiveinvestors.com/companies/news/173181/reneuron-makes-a-guest-appearance-on-bbc2-173181.html ReNeuron CFO 'very encouraged' with stroke study results https://ca.proactiveinvestors.com/companies/news/306569/reneuron-cfo-very-encouraged-with-stroke-study-results-6569.html Wed, 07 Dec 2016 15:52:00 -0500 https://ca.proactiveinvestors.com/companies/news/306569/reneuron-cfo-very-encouraged-with-stroke-study-results-6569.html ReNeuron makes strong start to key trial period https://ca.proactiveinvestors.com/companies/news/170119/reneuron-makes-strong-start-to-key-trial-period-170119.html Wed, 07 Dec 2016 13:00:00 -0500 https://ca.proactiveinvestors.com/companies/news/170119/reneuron-makes-strong-start-to-key-trial-period-170119.html ReNeuron chief delighted with latest stroke data https://ca.proactiveinvestors.com/companies/news/169950/reneuron-chief-delighted-with-latest-stroke-data-169950.html Mon, 05 Dec 2016 08:19:00 -0500 https://ca.proactiveinvestors.com/companies/news/169950/reneuron-chief-delighted-with-latest-stroke-data-169950.html ReNeuron ready to rally https://ca.proactiveinvestors.com/companies/news/306286/reneuron-ready-to-rally-6286.html Fri, 28 Oct 2016 13:45:00 -0400 https://ca.proactiveinvestors.com/companies/news/306286/reneuron-ready-to-rally-6286.html Are ReNeuron shares ready to explode? https://ca.proactiveinvestors.com/companies/news/168217/are-reneuron-shares-ready-to-explode-168217.html Fri, 28 Oct 2016 13:30:00 -0400 https://ca.proactiveinvestors.com/companies/news/168217/are-reneuron-shares-ready-to-explode-168217.html ReNeuron Group will hit "milestone" with results next year, says CEO https://ca.proactiveinvestors.com/companies/news/156975/reneuron-group-will-hit-milestone-with-results-next-year-says-ceo-156975.html Tue, 06 Sep 2016 08:23:00 -0400 https://ca.proactiveinvestors.com/companies/news/156975/reneuron-group-will-hit-milestone-with-results-next-year-says-ceo-156975.html ReNeuron scores coup in stroke drug development bid https://ca.proactiveinvestors.com/companies/news/305392/reneuron-scores-coup-in-stroke-drug-development-bid-5392.html Fri, 12 Aug 2016 10:13:00 -0400 https://ca.proactiveinvestors.com/companies/news/305392/reneuron-scores-coup-in-stroke-drug-development-bid-5392.html ReNeuron stroke results to be showcased in premier medical journal https://ca.proactiveinvestors.com/companies/news/128993/reneuron-stroke-results-to-be-showcased-in-premier-medical-journal-128993.html Thu, 04 Aug 2016 06:30:00 -0400 https://ca.proactiveinvestors.com/companies/news/128993/reneuron-stroke-results-to-be-showcased-in-premier-medical-journal-128993.html ReNeuron publishes positive pre-clinical data from its retinitis pigmentosa programme https://ca.proactiveinvestors.com/companies/news/305312/reneuron-publishes-positive-pre-clinical-data-from-its-retinitis-pigmentosa-programme-5312.html Fri, 22 Jul 2016 11:32:00 -0400 https://ca.proactiveinvestors.com/companies/news/305312/reneuron-publishes-positive-pre-clinical-data-from-its-retinitis-pigmentosa-programme-5312.html ReNeuron unveils positive pre-clinical data from eye trial https://ca.proactiveinvestors.com/companies/news/128499/reneuron-unveils-positive-pre-clinical-data-from-eye-trial-128499.html Fri, 22 Jul 2016 06:33:00 -0400 https://ca.proactiveinvestors.com/companies/news/128499/reneuron-unveils-positive-pre-clinical-data-from-eye-trial-128499.html Major milestones ahead, says ReNeuron CFO Michael Hunt https://ca.proactiveinvestors.com/companies/news/305251/major-milestones-ahead-says-reneuron-cfo-michael-hunt-5251.html Fri, 08 Jul 2016 10:42:00 -0400 https://ca.proactiveinvestors.com/companies/news/305251/major-milestones-ahead-says-reneuron-cfo-michael-hunt-5251.html ReNeuron hails a year of significant progress https://ca.proactiveinvestors.com/companies/news/127940/reneuron-hails-a-year-of-significant-progress-127940.html Thu, 07 Jul 2016 07:20:00 -0400 https://ca.proactiveinvestors.com/companies/news/127940/reneuron-hails-a-year-of-significant-progress-127940.html ReNeuron completes recruitment for phase II stroke trial https://ca.proactiveinvestors.com/companies/news/127036/reneuron-completes-recruitment-for-phase-ii-stroke-trial-127036.html Mon, 13 Jun 2016 07:33:00 -0400 https://ca.proactiveinvestors.com/companies/news/127036/reneuron-completes-recruitment-for-phase-ii-stroke-trial-127036.html ReNeuron to tackle brain cancer with exosome candidate https://ca.proactiveinvestors.com/companies/news/126929/reneuron-to-tackle-brain-cancer-with-exosome-candidate-126929.html Thu, 09 Jun 2016 07:43:00 -0400 https://ca.proactiveinvestors.com/companies/news/126929/reneuron-to-tackle-brain-cancer-with-exosome-candidate-126929.html ReNeuron making good progress in clinical trial, says CFO https://ca.proactiveinvestors.com/companies/news/305125/reneuron-making-good-progress-in-clinical-trial-says-cfo-5125.html Wed, 08 Jun 2016 14:51:00 -0400 https://ca.proactiveinvestors.com/companies/news/305125/reneuron-making-good-progress-in-clinical-trial-says-cfo-5125.html ReNeuron clinical trial making progress https://ca.proactiveinvestors.com/companies/news/126857/reneuron-clinical-trial-making-progress-126857.html Wed, 08 Jun 2016 06:41:00 -0400 https://ca.proactiveinvestors.com/companies/news/126857/reneuron-clinical-trial-making-progress-126857.html ReNeuron's Hunt says next significant milestone will be data from strokes study https://ca.proactiveinvestors.com/companies/news/304777/reneuron-s-hunt-says-next-significant-milestone-will-be-data-from-strokes-study-4777.html Tue, 15 Mar 2016 14:32:00 -0400 https://ca.proactiveinvestors.com/companies/news/304777/reneuron-s-hunt-says-next-significant-milestone-will-be-data-from-strokes-study-4777.html ReNeuron Group PLC treats first patient in retinitis pigmentosa trial https://ca.proactiveinvestors.com/companies/news/123679/reneuron-group-plc-treats-first-patient-in-retinitis-pigmentosa-trial-123679.html Tue, 15 Mar 2016 09:01:00 -0400 https://ca.proactiveinvestors.com/companies/news/123679/reneuron-group-plc-treats-first-patient-in-retinitis-pigmentosa-trial-123679.html ReNeuron eyeing data rich period as it progresses four opportunities https://ca.proactiveinvestors.com/companies/news/122972/reneuron-eyeing-data-rich-period-as-it-progresses-four-opportunities-122972.html Thu, 25 Feb 2016 08:01:00 -0500 https://ca.proactiveinvestors.com/companies/news/122972/reneuron-eyeing-data-rich-period-as-it-progresses-four-opportunities-122972.html ReNeuron heads west to find new home in Wales https://ca.proactiveinvestors.com/companies/news/122841/reneuron-heads-west-to-find-new-home-in-wales-122841.html Tue, 23 Feb 2016 08:19:00 -0500 https://ca.proactiveinvestors.com/companies/news/122841/reneuron-heads-west-to-find-new-home-in-wales-122841.html ReNeuron gets notice of US cryptopreservation patent https://ca.proactiveinvestors.com/companies/news/121979/reneuron-gets-notice-of-us-cryptopreservation-patent-121979.html Mon, 01 Feb 2016 08:47:00 -0500 https://ca.proactiveinvestors.com/companies/news/121979/reneuron-gets-notice-of-us-cryptopreservation-patent-121979.html ReNeuron reveals anti-cancer properties of cell line https://ca.proactiveinvestors.com/companies/news/121197/reneuron-reveals-anti-cancer-properties-of-cell-line-121197.html Tue, 12 Jan 2016 07:33:00 -0500 https://ca.proactiveinvestors.com/companies/news/121197/reneuron-reveals-anti-cancer-properties-of-cell-line-121197.html ReNeuron secures £2.1mln govt grant https://ca.proactiveinvestors.com/companies/news/121148/reneuron-secures-21mln-govt-grant-121148.html Mon, 11 Jan 2016 07:17:00 -0500 https://ca.proactiveinvestors.com/companies/news/121148/reneuron-secures-21mln-govt-grant-121148.html ReNeuron establishes scientific advisory board https://ca.proactiveinvestors.com/companies/news/120568/reneuron-establishes-scientific-advisory-board-120568.html Thu, 17 Dec 2015 07:33:00 -0500 https://ca.proactiveinvestors.com/companies/news/120568/reneuron-establishes-scientific-advisory-board-120568.html UPDATE - ReNeuron's third trial gets underway, first in US https://ca.proactiveinvestors.com/companies/news/120105/update-reneuron-s-third-trial-gets-underway-first-in-us-120105.html Mon, 07 Dec 2015 14:23:00 -0500 https://ca.proactiveinvestors.com/companies/news/120105/update-reneuron-s-third-trial-gets-underway-first-in-us-120105.html ReNeuron’s portfolio progressing on multiple fronts, says CEO https://ca.proactiveinvestors.com/companies/news/304446/reneurons-portfolio-progressing-on-multiple-fronts-says-ceo-4446.html Mon, 07 Dec 2015 13:11:00 -0500 https://ca.proactiveinvestors.com/companies/news/304446/reneurons-portfolio-progressing-on-multiple-fronts-says-ceo-4446.html ReNeuron adds former Glaxo biotech veteran to board https://ca.proactiveinvestors.com/companies/news/120048/reneuron-adds-former-glaxo-biotech-veteran-to-board-120048.html Fri, 04 Dec 2015 07:45:00 -0500 https://ca.proactiveinvestors.com/companies/news/120048/reneuron-adds-former-glaxo-biotech-veteran-to-board-120048.html Reneuron CFO Michael Hunt puts the investment case forwards for ReNeuron https://ca.proactiveinvestors.com/companies/news/304421/reneuron-cfo-michael-hunt-puts-the-investment-case-forwards-for-reneuron-4421.html Fri, 27 Nov 2015 13:22:00 -0500 https://ca.proactiveinvestors.com/companies/news/304421/reneuron-cfo-michael-hunt-puts-the-investment-case-forwards-for-reneuron-4421.html ReNeuron set for progress over the next three years https://ca.proactiveinvestors.com/companies/news/111094/reneuron-set-for-progress-over-the-next-three-years-111094.html Thu, 24 Sep 2015 06:45:00 -0400 https://ca.proactiveinvestors.com/companies/news/111094/reneuron-set-for-progress-over-the-next-three-years-111094.html ReNeuron confirms £68.4mln Woodford-backed placing https://ca.proactiveinvestors.com/companies/news/110257/ReNeuron-confirms-%C2%A368.4mln-Woodford-backed-placing-110257.html Tue, 25 Aug 2015 09:54:00 -0400 https://ca.proactiveinvestors.com/companies/news/110257/ReNeuron-confirms-%C2%A368.4mln-Woodford-backed-placing-110257.html ReNeuron shares sharply higher after £68.4 million placing https://ca.proactiveinvestors.com/companies/news/303929/reneuron-shares-sharply-higher-after-684-million-placing-3929.html Fri, 10 Jul 2015 14:12:00 -0400 https://ca.proactiveinvestors.com/companies/news/303929/reneuron-shares-sharply-higher-after-684-million-placing-3929.html ReNeuron gets Woodford's backing as it raises £68mln https://ca.proactiveinvestors.com/companies/news/108872/reneuron-gets-woodford-s-backing-as-it-raises-68mln-108872.html Fri, 10 Jul 2015 11:56:00 -0400 https://ca.proactiveinvestors.com/companies/news/108872/reneuron-gets-woodford-s-backing-as-it-raises-68mln-108872.html UPDATE - ReNeuron extends collaboration with Australian biotech https://ca.proactiveinvestors.com/companies/news/108236/update-reneuron-extends-collaboration-with-australian-biotech-108236.html Mon, 22 Jun 2015 13:30:00 -0400 https://ca.proactiveinvestors.com/companies/news/108236/update-reneuron-extends-collaboration-with-australian-biotech-108236.html ReNeuron beefs up management as overseas ambitions grow https://ca.proactiveinvestors.com/companies/news/107929/reneuron-beefs-up-management-as-overseas-ambitions-grow-107929.html Thu, 11 Jun 2015 07:18:00 -0400 https://ca.proactiveinvestors.com/companies/news/107929/reneuron-beefs-up-management-as-overseas-ambitions-grow-107929.html ReNeuron CFO: Fast-track gives programme ‘best possible chance’ https://ca.proactiveinvestors.com/companies/news/303794/reneuron-cfo-fast-track-gives-programme-best-possible-chance Fri, 22 May 2015 10:06:00 -0400 https://ca.proactiveinvestors.com/companies/news/303794/reneuron-cfo-fast-track-gives-programme-best-possible-chance ReNeuron's eye disease treatment placed on fast-track by US regulator https://ca.proactiveinvestors.com/companies/news/107129/reneuron-s-eye-disease-treatment-placed-on-fast-track-by-us-regulator-107129.html Fri, 22 May 2015 06:28:00 -0400 https://ca.proactiveinvestors.com/companies/news/107129/reneuron-s-eye-disease-treatment-placed-on-fast-track-by-us-regulator-107129.html Toscafund sells stake in ReNeuron https://ca.proactiveinvestors.com/companies/news/106806/toscafund-sells-stake-in-reneuron-106806.html Fri, 15 May 2015 08:06:00 -0400 https://ca.proactiveinvestors.com/companies/news/106806/toscafund-sells-stake-in-reneuron-106806.html UPDATE - ReNeuron gains regulatory green light for first ever US clinical trial https://ca.proactiveinvestors.com/companies/news/68665/update-reneuron-gains-regulatory-green-light-for-first-ever-us-clinical-trial--79976.html Tue, 05 May 2015 14:17:00 -0400 https://ca.proactiveinvestors.com/companies/news/68665/update-reneuron-gains-regulatory-green-light-for-first-ever-us-clinical-trial--79976.html ReNeuron's 'buy' rating reiterated after stroke conference https://ca.proactiveinvestors.com/companies/news/68205/reneurons-buy-rating-reiterated-after-stroke-conference-79466.html Mon, 20 Apr 2015 16:10:00 -0400 https://ca.proactiveinvestors.com/companies/news/68205/reneurons-buy-rating-reiterated-after-stroke-conference-79466.html ReNeuron heartened by stroke trial data https://ca.proactiveinvestors.com/companies/news/68147/reneuron-heartened-by-stroke-trial-data-79405.html Shares in ReNeuron rose sharply following an update on a Phase I clinical trial of ReNeuron’s CTX stem cell therapy for disabled stroke patients.  

]]>
Fri, 17 Apr 2015 14:06:00 -0400 https://ca.proactiveinvestors.com/companies/news/68147/reneuron-heartened-by-stroke-trial-data-79405.html
UPDATE - ReNeuron set to launch first US clinical trial in US with eye disease stem cell treatment https://ca.proactiveinvestors.com/companies/news/67953/update-reneuron-set-to-launch-first-us-clinical-trial-in-us-with-eye-disease-stem-cell-treatment-79195.html Mon, 13 Apr 2015 13:30:00 -0400 https://ca.proactiveinvestors.com/companies/news/67953/update-reneuron-set-to-launch-first-us-clinical-trial-in-us-with-eye-disease-stem-cell-treatment-79195.html ReNeuron appoints new chair, strengthens management team https://ca.proactiveinvestors.com/companies/news/67694/reneuron-appoints-new-chair-strengthens-management-team-78912.html Wed, 01 Apr 2015 08:26:00 -0400 https://ca.proactiveinvestors.com/companies/news/67694/reneuron-appoints-new-chair-strengthens-management-team-78912.html ReNeuron phase 2 stem cell trials still on track https://ca.proactiveinvestors.com/companies/news/303058/reneuron-phase-2-stem-cell-trials-still-on-track--3506.html Fri, 20 Feb 2015 12:35:00 -0500 https://ca.proactiveinvestors.com/companies/news/303058/reneuron-phase-2-stem-cell-trials-still-on-track--3506.html Biotechs to continue momentum after record year, Cenkos says https://ca.proactiveinvestors.com/companies/news/66165/biotechs-to-continue-momentum-after-record-year-cenkos-says-77234.html The performance of healthcare and biotechnology benchmarks in both the US and UK indices has been impressive, all of which begs the question: is this a bubble?

]]>
Thu, 12 Feb 2015 11:19:00 -0500 https://ca.proactiveinvestors.com/companies/news/66165/biotechs-to-continue-momentum-after-record-year-cenkos-says-77234.html
ReNeuron has potential to establish attractive deals https://ca.proactiveinvestors.com/companies/news/64421/reneuron-has-potential-to-establish-attractive-deals-75254.html Broker N+1 Singer has initiated coverage of stem cell therapy developer ReNeuron with a ‘buy’ recommendation and 6.2p price target.

]]>
Wed, 10 Dec 2014 10:42:00 -0500 https://ca.proactiveinvestors.com/companies/news/64421/reneuron-has-potential-to-establish-attractive-deals-75254.html
UPDATE - ReNeuron focused on delivery https://ca.proactiveinvestors.com/companies/news/63669/update-reneuron-focused-on-delivery-74402.html Mon, 17 Nov 2014 11:42:00 -0500 https://ca.proactiveinvestors.com/companies/news/63669/update-reneuron-focused-on-delivery-74402.html BIG PICTURE: ReNeuron at pivotal point in its history https://ca.proactiveinvestors.com/companies/news/61600/big-picture-reneuron-at-pivotal-point-in-its-history-72080.html With an important number of value inflection points between now and the end of 2015, ReNeuron is at a pivotal point in its history.

]]>
Wed, 10 Sep 2014 10:59:00 -0400 https://ca.proactiveinvestors.com/companies/news/61600/big-picture-reneuron-at-pivotal-point-in-its-history-72080.html
UPDATE - ReNeuron appoints ex-Clavis Pharma boss as new CEO https://ca.proactiveinvestors.com/companies/news/61493/update-reneuron-appoints-ex-clavis-pharma-boss-as-new-ceo-71969.html Mon, 08 Sep 2014 12:17:00 -0400 https://ca.proactiveinvestors.com/companies/news/61493/update-reneuron-appoints-ex-clavis-pharma-boss-as-new-ceo-71969.html ReNeuron says dosing of patients in two clinical trials has started https://ca.proactiveinvestors.com/companies/news/61333/reneuron-says-dosing-of-patients-in-two-clinical-trials-has-started-71795.html Tue, 02 Sep 2014 06:59:00 -0400 https://ca.proactiveinvestors.com/companies/news/61333/reneuron-says-dosing-of-patients-in-two-clinical-trials-has-started-71795.html ReNeuron upbeat after "transformational" year https://ca.proactiveinvestors.com/companies/news/59204/reneuron-upbeat-after-transformational-year-69549.html Wed, 18 Jun 2014 06:09:00 -0400 https://ca.proactiveinvestors.com/companies/news/59204/reneuron-upbeat-after-transformational-year-69549.html ReNeuron: No adverse effects in PISCES trial https://ca.proactiveinvestors.com/companies/news/58015/reneuron-no-adverse-effects-in-pisces-trial-68278.html Wed, 07 May 2014 06:39:00 -0400 https://ca.proactiveinvestors.com/companies/news/58015/reneuron-no-adverse-effects-in-pisces-trial-68278.html ReNeuron chief to move to CFO role as co looks to "reconfigure" board https://ca.proactiveinvestors.com/companies/news/57591/reneuron-chief-to-move-to-cfo-role-as-co-looks-to-reconfigure-board-67830.html Wed, 23 Apr 2014 06:39:00 -0400 https://ca.proactiveinvestors.com/companies/news/57591/reneuron-chief-to-move-to-cfo-role-as-co-looks-to-reconfigure-board-67830.html ReNeuron seals South Wales move https://ca.proactiveinvestors.com/companies/news/57411/reneuron-seals-south-wales-move-67646.html Tue, 15 Apr 2014 06:31:00 -0400 https://ca.proactiveinvestors.com/companies/news/57411/reneuron-seals-south-wales-move-67646.html Pace of progress quickens at ReNeuron as it gets set to launch two clinical trials https://ca.proactiveinvestors.com/companies/news/56858/pace-of-progress-quickens-at-reneuron-as-it-gets-set-to-launch-two-clinical-trials-67064.html Stem cell research group ReNeuron will step up activity after receiving regulatory approval for two clinical trials.

]]>
Thu, 27 Mar 2014 06:28:00 -0400 https://ca.proactiveinvestors.com/companies/news/56858/pace-of-progress-quickens-at-reneuron-as-it-gets-set-to-launch-two-clinical-trials-67064.html
ReNeuron's retinal treatment potentially in clinical trial in 2014 https://ca.proactiveinvestors.com/companies/news/302306/reneurons-retinal-treatment-potentially-in-clinical-trial-in-2014-2618.html Mon, 17 Mar 2014 09:37:00 -0400 https://ca.proactiveinvestors.com/companies/news/302306/reneurons-retinal-treatment-potentially-in-clinical-trial-in-2014-2618.html ReNeuron welcomes UK government's early access scheme https://ca.proactiveinvestors.com/companies/news/56508/reneuron-welcomes-uk-governments-early-access-scheme-66689.html Fri, 14 Mar 2014 13:02:00 -0400 https://ca.proactiveinvestors.com/companies/news/56508/reneuron-welcomes-uk-governments-early-access-scheme-66689.html ReNeuron to receive more external funding for eye treatment https://ca.proactiveinvestors.com/companies/news/56392/reneuron-to-receive-more-external-funding-for-eye-treatment-66556.html Tue, 11 Mar 2014 07:29:00 -0400 https://ca.proactiveinvestors.com/companies/news/56392/reneuron-to-receive-more-external-funding-for-eye-treatment-66556.html ReNeuron's frozen CTX cell product potentially a "major competitive advantage" https://ca.proactiveinvestors.com/companies/news/53786/reneurons-frozen-ctx-cell-product-potentially-a-major-competitive-advantage-63795.html ReNeuron is to speed up the development of an extended shelf-life version of the CTX drug product, while it also working on an additional therapeutic platform relating to exosomes, nanoparticles that could help in wound healing, immune modulation, neuro-protection and restriction of cancer proliferation.

]]>
Mon, 02 Dec 2013 12:11:00 -0500 https://ca.proactiveinvestors.com/companies/news/53786/reneurons-frozen-ctx-cell-product-potentially-a-major-competitive-advantage-63795.html
ReNeuron making strong progress on all fronts https://ca.proactiveinvestors.com/companies/news/53772/reneuron-making-strong-progress-on-all-fronts-63779.html Mon, 02 Dec 2013 07:13:00 -0500 https://ca.proactiveinvestors.com/companies/news/53772/reneuron-making-strong-progress-on-all-fronts-63779.html ReNeuron sticks to timeline after impressive progress https://ca.proactiveinvestors.com/companies/news/51350/reneuron-sticks-to-timeline-after-impressive-progress-61053.html Fri, 13 Sep 2013 06:52:00 -0400 https://ca.proactiveinvestors.com/companies/news/51350/reneuron-sticks-to-timeline-after-impressive-progress-61053.html Q&A: ReNeuron on a roll as gains orphan status for eye disease therapy https://ca.proactiveinvestors.com/companies/news/51024/qa-reneuron-on-a-roll-as-gains-orphan-status-for-eye-disease-therapy-60688.html Proactive Investors recently caught up with Michael Hunt, chief executive of stem cell specialist ReNeuron.

]]>
Tue, 03 Sep 2013 11:53:00 -0400 https://ca.proactiveinvestors.com/companies/news/51024/qa-reneuron-on-a-roll-as-gains-orphan-status-for-eye-disease-therapy-60688.html
ReNeuron chief on orphan status for eye treatment https://ca.proactiveinvestors.com/companies/news/301919/reneuron-chief-on-orphan-status-for-eye-treatment-2156.html Fri, 30 Aug 2013 07:41:00 -0400 https://ca.proactiveinvestors.com/companies/news/301919/reneuron-chief-on-orphan-status-for-eye-treatment-2156.html UPDATE- ReNeuron stem cell therapy for eye disease singled out for special treatment in US and EU https://ca.proactiveinvestors.com/companies/news/50854/update-reneuron-stem-cell-therapy-for-eye-disease-singled-out-for-special-treatment-in-us-and-eu-60501.html AIM-listed ReNeuron said it has received orphan drug status in the world’s two biggest markets for its stem cell therapy to tackle a rare degenerative eye disease.

]]>
Thu, 29 Aug 2013 12:41:00 -0400 https://ca.proactiveinvestors.com/companies/news/50854/update-reneuron-stem-cell-therapy-for-eye-disease-singled-out-for-special-treatment-in-us-and-eu-60501.html
Biotechs coming back into focus https://ca.proactiveinvestors.com/companies/news/50725/biotechs-coming-back-into-focus--60353.html Enjoying a revival of sorts, after many years of being out of favour, are the biotechs. Biotechnology is the catch-all term used here in Britain to define a few dozen drug developers with low market valuations, but high hopes of discovering the next blockbuster treatment.

]]>
Mon, 26 Aug 2013 08:45:00 -0400 https://ca.proactiveinvestors.com/companies/news/50725/biotechs-coming-back-into-focus--60353.html
ReNeuron: Wales Life Sciences fund's stake is 11.2% https://ca.proactiveinvestors.com/companies/news/50355/reneuron-wales-life-sciences-funds-stake-is-112-59925.html Mon, 12 Aug 2013 07:01:00 -0400 https://ca.proactiveinvestors.com/companies/news/50355/reneuron-wales-life-sciences-funds-stake-is-112-59925.html ReNeuron gets further support from Technology Strategy Board https://ca.proactiveinvestors.com/companies/news/50062/reneuron-gets-further-support-from-technology-strategy-board-59614.html Thu, 01 Aug 2013 06:16:00 -0400 https://ca.proactiveinvestors.com/companies/news/50062/reneuron-gets-further-support-from-technology-strategy-board-59614.html UPDATE: ReNeuron puts funding fears to bed https://ca.proactiveinvestors.com/companies/news/49735/update-reneuron-puts-funding-fears-to-bed-59231.html ReNeuron has received strong backing for its therapeutic programmes, with institutional shareholders pumping £25.4mln into the company, while the Welsh government has chipped in with a £7.8mln grant.

]]>
Mon, 22 Jul 2013 14:56:00 -0400 https://ca.proactiveinvestors.com/companies/news/49735/update-reneuron-puts-funding-fears-to-bed-59231.html
ReNeuron welcomes findings of House of Lords committee on regenerative medicine https://ca.proactiveinvestors.com/companies/news/49143/reneuron-welcomes-findings-of-house-of-lords-committee-on-regenerative-medicine-58545.html Mon, 01 Jul 2013 07:07:00 -0400 https://ca.proactiveinvestors.com/companies/news/49143/reneuron-welcomes-findings-of-house-of-lords-committee-on-regenerative-medicine-58545.html Update: ReNeuron encouraged by ReN001 test results https://ca.proactiveinvestors.com/companies/news/48114/update-reneuron-encouraged-by-ren001-test-results-57348.html Tue, 28 May 2013 15:18:00 -0400 https://ca.proactiveinvestors.com/companies/news/48114/update-reneuron-encouraged-by-ren001-test-results-57348.html ReNeuron to unveil results of tissue repair tests https://ca.proactiveinvestors.com/companies/news/46944/reneuron-to-unveil-results-of-tissue-repair-tests-55982.html Fri, 19 Apr 2013 06:40:00 -0400 https://ca.proactiveinvestors.com/companies/news/46944/reneuron-to-unveil-results-of-tissue-repair-tests-55982.html ReNeuron aims to accelerate cell manufacturing technologies https://ca.proactiveinvestors.com/companies/news/301690/reneuron-aims-to-accelerate-cell-manufacturing-technologies--1880.html Thu, 28 Mar 2013 15:10:00 -0400 https://ca.proactiveinvestors.com/companies/news/301690/reneuron-aims-to-accelerate-cell-manufacturing-technologies--1880.html ReNeuron uses Catapult to advance its studies https://ca.proactiveinvestors.com/companies/news/46307/reneuron-uses-catapult-to-advance-its-studies--55246.html Thu, 28 Mar 2013 06:25:00 -0400 https://ca.proactiveinvestors.com/companies/news/46307/reneuron-uses-catapult-to-advance-its-studies--55246.html ReNeuron passes another milestone in development of ReN001 https://ca.proactiveinvestors.com/companies/news/46279/reneuron-passes-another-milestone-in-development-of-ren001-55213.html Wed, 27 Mar 2013 08:01:00 -0400 https://ca.proactiveinvestors.com/companies/news/46279/reneuron-passes-another-milestone-in-development-of-ren001-55213.html ReNeuron green light for new clinical trial https://ca.proactiveinvestors.com/companies/news/46241/reneuron-green-light-for-new-clinical-trial--55168.html ReNeuron has received regulatory and ethical approvals to begin phase I clinical trials on its ReN009 stem cell therapy for critical limb ischaemia.

]]>
Tue, 26 Mar 2013 07:10:00 -0400 https://ca.proactiveinvestors.com/companies/news/46241/reneuron-green-light-for-new-clinical-trial--55168.html
UPDATE: ReNeuron progress endorsed as it receives £1.2mln funding injection https://ca.proactiveinvestors.com/companies/news/45769/update-reneuron-progress-endorsed-as-it-receives-12mln-funding-injection-54616.html ReNeuron has won two separate grants totalling £1.2mln that will be used to fund its stem cell research programme. Welcome though the cash is, chief executive Michael Hunt said the signals the awards send out to other stakeholders about the strength and breadth of the company’s development programme were just as important.

]]>
Mon, 11 Mar 2013 14:51:00 -0400 https://ca.proactiveinvestors.com/companies/news/45769/update-reneuron-progress-endorsed-as-it-receives-12mln-funding-injection-54616.html
ReNeuron begins dosing final group of stroke patients https://ca.proactiveinvestors.com/companies/news/44413/reneuron-begins-dosing-final-group-of-stroke-patients-52989.html ReNeuron said it has begun dosing the final group, or cohort, of three patients with its stem cell therapy for ischaemic stroke. The independent Data Safety Monitoring Board has given the sign off top move onto this last group following the review of three month follow-up data on an earlier cohort.

]]>
Tue, 29 Jan 2013 06:39:00 -0500 https://ca.proactiveinvestors.com/companies/news/44413/reneuron-begins-dosing-final-group-of-stroke-patients-52989.html
ReNeuron progressed as planned in first half https://ca.proactiveinvestors.com/companies/news/42843/reneuron-progressed-as-planned-in-first-half-51156.html Tue, 04 Dec 2012 08:21:00 -0500 https://ca.proactiveinvestors.com/companies/news/42843/reneuron-progressed-as-planned-in-first-half-51156.html ReNeuron says academic papers underline the potential of stem cell therapy in stroke https://ca.proactiveinvestors.com/companies/news/42457/reneuron-says-academic-papers-underline-the-potential-of-stem-cell-therapy-in-stroke-50670.html ReNeuron said two academic papers appear to provide further evidence of the potential of CTX neural stem cells to alleviate the “disabling consequences of a stroke”.

]]>
Thu, 22 Nov 2012 06:51:00 -0500 https://ca.proactiveinvestors.com/companies/news/42457/reneuron-says-academic-papers-underline-the-potential-of-stem-cell-therapy-in-stroke-50670.html
ReNeuron shares advance as it hits another milestone in stem cell trials https://ca.proactiveinvestors.com/companies/news/41297/reneuron-shares-advance-as-it-hits-another-milestone-in-stem-cell-trials-49247.html This morning ReNeuron said it has successfully treated all three patients in the penultimate dose cohort in the clinical trial for its stem cell therapy for disabled stroke patients.

]]>
Wed, 17 Oct 2012 07:36:00 -0400 https://ca.proactiveinvestors.com/companies/news/41297/reneuron-shares-advance-as-it-hits-another-milestone-in-stem-cell-trials-49247.html
Reneuron submits new trial applications for stroke and limb ischaemia https://ca.proactiveinvestors.com/companies/news/40180/reneuron-submits-new-trial-applications-for-stroke-and-limb-ischaemia--47944.html Tue, 11 Sep 2012 07:10:00 -0400 https://ca.proactiveinvestors.com/companies/news/40180/reneuron-submits-new-trial-applications-for-stroke-and-limb-ischaemia--47944.html ReNeuron’s stroke therapy given green light by safety board https://ca.proactiveinvestors.com/companies/news/39176/reneurons-stroke-therapy-given-green-light-by-safety-board-46783.html

The stem cell specialist has revealed the clinical trial of its therapy for disabled stroke patients has been given the go-ahead by the independent Data Safety Monitoring Board.

]]>
Tue, 14 Aug 2012 07:07:00 -0400 https://ca.proactiveinvestors.com/companies/news/39176/reneurons-stroke-therapy-given-green-light-by-safety-board-46783.html
ReNeuron recruits Colin Blakemore advisory group https://ca.proactiveinvestors.com/companies/news/37442/reneuron-recruits-colin-blakemore-advisory-group--44764.html ReNeuron said this morning it has recruited Professor Colin Blakemore, the former chief executive of the Medical Research Council, to join the stem cell specialist’s new scientific and strategic advisory group

]]>
Thu, 28 Jun 2012 07:19:00 -0400 https://ca.proactiveinvestors.com/companies/news/37442/reneuron-recruits-colin-blakemore-advisory-group--44764.html
ReNeuron to showcase pre-clinical data at major stem cell conference https://ca.proactiveinvestors.com/companies/news/36957/reneuron-to-showcase-pre-clinical-data-at-major-stem-cell-conference-44195.html Fri, 15 Jun 2012 07:14:00 -0400 https://ca.proactiveinvestors.com/companies/news/36957/reneuron-to-showcase-pre-clinical-data-at-major-stem-cell-conference-44195.html ReNeuron data yields encouraging results https://ca.proactiveinvestors.com/companies/news/36898/reneuron-data-yields-encouraging-results-44120.html ReNeuron Group said this morning it is encouraged by the latest data from its pilot investigation of stem cells in stroke, or PISCES study, being carried out in Scotland.

]]>
Thu, 14 Jun 2012 06:39:00 -0400 https://ca.proactiveinvestors.com/companies/news/36898/reneuron-data-yields-encouraging-results-44120.html
ReNeuron Prochymal approval "defining moment" for stem cell research https://ca.proactiveinvestors.com/companies/news/36016/reneuron-prochymal-approval-defining-moment-for-stem-cell-research-43058.html Mon, 21 May 2012 06:49:00 -0400 https://ca.proactiveinvestors.com/companies/news/36016/reneuron-prochymal-approval-defining-moment-for-stem-cell-research-43058.html ReNeuron signs cell manufacturing deal with Angel Biotechnology https://ca.proactiveinvestors.com/companies/news/35871/reneuron-signs-cell-manufacturing-deal-with-angel-biotechnology-42879.html Wed, 16 May 2012 06:51:00 -0400 https://ca.proactiveinvestors.com/companies/news/35871/reneuron-signs-cell-manufacturing-deal-with-angel-biotechnology-42879.html ReNeuron Group says Majedie Asset Management raises stake to 5.34pct https://ca.proactiveinvestors.com/companies/news/35705/reneuron-group-says-majedie-asset-management-raises-stake-to-534pct-42662.html Fri, 11 May 2012 10:32:00 -0400 https://ca.proactiveinvestors.com/companies/news/35705/reneuron-group-says-majedie-asset-management-raises-stake-to-534pct-42662.html ReNeuron raises over £6 million for stem cell research and development https://ca.proactiveinvestors.com/companies/news/35201/reneuron-raises-over-6-million-for-stem-cell-research-and-development-42019.html The stem cell specialist ReNeuron said it had successfully raised over £6 million to fund its ongoing research and development programme.

 

]]>
Fri, 27 Apr 2012 06:50:00 -0400 https://ca.proactiveinvestors.com/companies/news/35201/reneuron-raises-over-6-million-for-stem-cell-research-and-development-42019.html
ReNeuron raises £9.4 million as trials advance https://ca.proactiveinvestors.com/companies/news/34470/reneuron-raises-94-million-as-trials-advance-41084.html Tue, 03 Apr 2012 09:30:00 -0400 https://ca.proactiveinvestors.com/companies/news/34470/reneuron-raises-94-million-as-trials-advance-41084.html ReNeuron CTX stem cell line holds up well under large-scale manufacturing conditions https://ca.proactiveinvestors.com/companies/news/31530/reneuron-ctx-stem-cell-line-holds-up-well-under-large-scale-manufacturing-conditions-37669.html ReNeuron said that its lead CTX neural stem cell line held up well under large-scale manufacturing conditions. The stress tests were carried out by professor Mike Hoare and his team at University College London.

 

]]>
Wed, 11 Jan 2012 06:26:00 -0500 https://ca.proactiveinvestors.com/companies/news/31530/reneuron-ctx-stem-cell-line-holds-up-well-under-large-scale-manufacturing-conditions-37669.html
ImmuPharma, Shire, ReNeuron and Epistem make it into Merchant's top 12 for 2012 https://ca.proactiveinvestors.com/companies/news/31415/immupharma-shire-reneuron-and-epistem-make-it-into-merchants-top-12-for-2012-37545.html This year is predicted to be one of mixed fortunes for the life sciences sector, according to Merchant Securities. Many of the larger pharmaceuticals companies such as Pfizer, Novartis and AstraZeneca are now facing what is known as the patent cliff. This is where blockbuster drugs lose their patent protection and come under heavy competition.

]]>
Fri, 06 Jan 2012 10:12:00 -0500 https://ca.proactiveinvestors.com/companies/news/31415/immupharma-shire-reneuron-and-epistem-make-it-into-merchants-top-12-for-2012-37545.html
ReNeuron shares spike 9 per cent on latest stroke data https://ca.proactiveinvestors.com/companies/news/31279/reneuron-shares-spike-9-per-cent-on-latest-stroke-data--37395.html Shares in ReNeuron opened 9 per cent higher today after the group unveiled encouraging pre-clinical data on the use of neural stem cells in stroke.

]]>
Tue, 03 Jan 2012 10:12:00 -0500 https://ca.proactiveinvestors.com/companies/news/31279/reneuron-shares-spike-9-per-cent-on-latest-stroke-data--37395.html
ReNeuron unveils more encouraging data on stem cell line https://ca.proactiveinvestors.com/companies/news/31261/reneuron-unveils-more-encouraging-data-on-stem-cell-line--37377.html ReNeuron this morning unveiled encouraging pre-clinical data on its CTX neural stem cell line in stroke which is to be included in the scientific journal Stem Cell.

]]>
Tue, 03 Jan 2012 06:43:00 -0500 https://ca.proactiveinvestors.com/companies/news/31261/reneuron-unveils-more-encouraging-data-on-stem-cell-line--37377.html
ReNeuron welcomes life sciences strategy from UK government https://ca.proactiveinvestors.com/companies/news/30618/reneuron-welcomes-life-sciences-strategy-from-uk-government-36610.html Tue, 06 Dec 2011 09:27:00 -0500 https://ca.proactiveinvestors.com/companies/news/30618/reneuron-welcomes-life-sciences-strategy-from-uk-government-36610.html ReNeuron makes “excellent progress” with PISCES stem cell trial https://ca.proactiveinvestors.com/companies/news/30289/reneuron-makes-excellent-progress-with-pisces-stem-cell-trial-36200.html Merchant Securities continues to rate the stem cell firm as a ‘buy’ with a 33 pence per share price target

]]>
Mon, 28 Nov 2011 11:01:00 -0500 https://ca.proactiveinvestors.com/companies/news/30289/reneuron-makes-excellent-progress-with-pisces-stem-cell-trial-36200.html
ReNeuron reports further progress with PISCES stem cell trial https://ca.proactiveinvestors.com/companies/news/30266/reneuron-reports-further-progress-with-pisces-stem-cell-trial-36177.html Mon, 28 Nov 2011 06:32:00 -0500 https://ca.proactiveinvestors.com/companies/news/30266/reneuron-reports-further-progress-with-pisces-stem-cell-trial-36177.html ReNeuron says 12 months on, first stroke patient remains well; no “cell-related adverse events" https://ca.proactiveinvestors.com/companies/news/29575/reneuron-says-12-months-on-first-stroke-patient-remains-well-no-cell-related-adverse-events-35361.html ReNeuron said this morning that the first ever stroke patient to be treated with its stem cell therapy remains well with no “cell-related adverse events reported”.

]]>
Wed, 09 Nov 2011 06:57:00 -0500 https://ca.proactiveinvestors.com/companies/news/29575/reneuron-says-12-months-on-first-stroke-patient-remains-well-no-cell-related-adverse-events-35361.html
ReNeuron: Toscafund increases stake in stem cell firm to 10 per cent https://ca.proactiveinvestors.com/companies/news/29276/reneuron-toscafund-increases-stake-in-stem-cell-firm-to-10-per-cent-34996.html Mon, 31 Oct 2011 11:38:00 -0400 https://ca.proactiveinvestors.com/companies/news/29276/reneuron-toscafund-increases-stake-in-stem-cell-firm-to-10-per-cent-34996.html ReNeuron to present at stem cell conference next week https://ca.proactiveinvestors.com/companies/news/28564/reneuron-to-present-at-stem-cell-conference-next-week-34139.html Mon, 10 Oct 2011 07:00:00 -0400 https://ca.proactiveinvestors.com/companies/news/28564/reneuron-to-present-at-stem-cell-conference-next-week-34139.html Merchant Securities initiates ReNeuron with 'buy' rating https://ca.proactiveinvestors.com/companies/news/28136/merchant-securities-initiates-reneuron-with-buy-rating-33610.html Tue, 27 Sep 2011 09:00:00 -0400 https://ca.proactiveinvestors.com/companies/news/28136/merchant-securities-initiates-reneuron-with-buy-rating-33610.html ReNeuron shares up as stem cell firm issues “confident” update https://ca.proactiveinvestors.com/companies/news/27768/reneuron-shares-up-as-stem-cell-firm-issues-confident-update-33173.html Analysts welcomed ReNeuron’s latest update ahead of its annual general meeting. The firm also plans to explore the potential of its ReN001 treatment in stroke survivors who are much earlier on in the process of recovering from their stroke

]]>
Thu, 15 Sep 2011 11:39:00 -0400 https://ca.proactiveinvestors.com/companies/news/27768/reneuron-shares-up-as-stem-cell-firm-issues-confident-update-33173.html
ReNeuron investigating the potential of using stem cell treatment earlier in stroke recovery process https://ca.proactiveinvestors.com/companies/news/27738/ReNeuron-investigating-the-potential-of-using-stem-cell-treatment-earlier-in-stroke-recovery-process-33153.html Stem cell specialist ReNeuron said this morning that it is looking at the potential of using its stroke treatment on patients earlier in the recovery process. 

]]>
Thu, 15 Sep 2011 06:32:00 -0400 https://ca.proactiveinvestors.com/companies/news/27738/ReNeuron-investigating-the-potential-of-using-stem-cell-treatment-earlier-in-stroke-recovery-process-33153.html
ReNeuron says first patient treated using higher dose of stem cell therapy https://ca.proactiveinvestors.com/companies/news/27659/reneuron-says-first-patient-treated-using-higher-dose-of-stem-cell-therapy--33036.html A stroke patient has been discharged from hospital after being treated with a higher dose of ReNeuron’s revolutionary stem cell therapy ReN001, it was revealed today.

]]>
Tue, 13 Sep 2011 06:51:00 -0400 https://ca.proactiveinvestors.com/companies/news/27659/reneuron-says-first-patient-treated-using-higher-dose-of-stem-cell-therapy--33036.html
UPDATE: ReNeuron receives clearance to increase the dose of its stem cell treatment for stroke https://ca.proactiveinvestors.com/companies/news/27318/update-reneuron-receives-clearance-to-increase-the-dose-of-its-stem-cell-treatment-for-stroke-32619.html ReNeuron has been cleared to administer higher doses of its stem cell treatment for stroke. The green light has been given by the Data Safety Monitoring Board, which assessed information gleaned from the use of ReN001 on three patients. City analysts had a broadly positve response to the news.

]]>
Thu, 01 Sep 2011 11:00:00 -0400 https://ca.proactiveinvestors.com/companies/news/27318/update-reneuron-receives-clearance-to-increase-the-dose-of-its-stem-cell-treatment-for-stroke-32619.html
ReNeuron receives clearance to increase the dose of its stem cell treatment for stroke https://ca.proactiveinvestors.com/companies/news/27299/ReNeuron-receives-clearance-to-increase-the-dose-of-its-stem-cell-treatment-for-stroke-32600.html

ReNeuron has been cleared to administer higher doses of its stem cell treatment for stroke. The green light has been given by the Data Safety Monitoring Board, which assessed information gleaned from the use of ReN001 on three patients.

]]>
Thu, 01 Sep 2011 06:34:00 -0400 https://ca.proactiveinvestors.com/companies/news/27299/ReNeuron-receives-clearance-to-increase-the-dose-of-its-stem-cell-treatment-for-stroke-32600.html
ReNeuron: stem cell pioneer making steady progress https://ca.proactiveinvestors.com/companies/news/27020/reneuron-stem-cell-pioneer-making-steady-progress-32251.html ReNeuron, the only firm so far to have received regulatory approval for a stem cell-based clinical trial in the UK, is seeing steady progress with its PISCES Phase I trial. Here, we take a look at the pioneering life sciences business

]]>
Tue, 23 Aug 2011 09:31:00 -0400 https://ca.proactiveinvestors.com/companies/news/27020/reneuron-stem-cell-pioneer-making-steady-progress-32251.html
UPDATE: ReNeuron Group appoints new directors and forms scientific advisory body https://ca.proactiveinvestors.com/companies/news/25900/update-reneuron-group-appoints-new-directors-and-forms-scientific-advisory-body-30919.html Wed, 20 Jul 2011 14:20:00 -0400 https://ca.proactiveinvestors.com/companies/news/25900/update-reneuron-group-appoints-new-directors-and-forms-scientific-advisory-body-30919.html ReNeuron Group appoints new directors and forms scientific advisory body https://ca.proactiveinvestors.com/companies/news/25868/reneuron-group-appoints-new-directors-and-forms-scientific-advisory-body-30884.html Wed, 20 Jul 2011 07:19:00 -0400 https://ca.proactiveinvestors.com/companies/news/25868/reneuron-group-appoints-new-directors-and-forms-scientific-advisory-body-30884.html ReNeuron materially undervalued - Daniel Stewart https://ca.proactiveinvestors.com/companies/news/25542/reneuron-materially-undervalued-daniel-stewart-30495.html Mon, 11 Jul 2011 13:53:00 -0400 https://ca.proactiveinvestors.com/companies/news/25542/reneuron-materially-undervalued-daniel-stewart-30495.html UPDATE: ReNeuron extends contract with Angel Biotechnology Holdings for ReN001 stem cell therapy https://ca.proactiveinvestors.com/companies/news/25314/update-reneuron-extends-contract-with-angel-biotechnology-holdings-for-ren001-stem-cell-therapy-30228.html Tue, 05 Jul 2011 14:45:00 -0400 https://ca.proactiveinvestors.com/companies/news/25314/update-reneuron-extends-contract-with-angel-biotechnology-holdings-for-ren001-stem-cell-therapy-30228.html ReNeuron sees losses widen on pipeline development https://ca.proactiveinvestors.com/companies/news/25138/reneuron-sees-losses-widen-on-pipeline-development-30041.html Thu, 30 Jun 2011 06:50:00 -0400 https://ca.proactiveinvestors.com/companies/news/25138/reneuron-sees-losses-widen-on-pipeline-development-30041.html ReNeuron signs agreement in US in bid to fight retina diseases https://ca.proactiveinvestors.com/companies/news/24651/reneuron-signs-agreement-in-us-in-bid-to-fight-retina-diseases--29455.html Thu, 16 Jun 2011 06:33:00 -0400 https://ca.proactiveinvestors.com/companies/news/24651/reneuron-signs-agreement-in-us-in-bid-to-fight-retina-diseases--29455.html UPDATE: ReNeuron treats third stroke patient in phase I trials of stem cell therapy https://ca.proactiveinvestors.com/companies/news/24065/update-reneuron-treats-third-stroke-patient-in-phase-i-trials-of-stem-cell-therapy-28731.html Fri, 27 May 2011 12:54:00 -0400 https://ca.proactiveinvestors.com/companies/news/24065/update-reneuron-treats-third-stroke-patient-in-phase-i-trials-of-stem-cell-therapy-28731.html ReNeuron treats third stroke patient in phase I trials of stem cell therapy https://ca.proactiveinvestors.com/companies/news/24044/reneuron-treats-third-stroke-patient-in-phase-i-trials-of-stem-cell-therapy-28709.html ReNeuron said this morning the last of the stroke patients in the initial dosing group has been treated with the group’s new stem cell therapy.

]]>
Fri, 27 May 2011 06:33:00 -0400 https://ca.proactiveinvestors.com/companies/news/24044/reneuron-treats-third-stroke-patient-in-phase-i-trials-of-stem-cell-therapy-28709.html
ReNeuron welcomes UK govt initiative to create cell therapy centre https://ca.proactiveinvestors.com/companies/news/23556/reneuron-welcomes-uk-govt-initiative-to-create-cell-therapy-centre--28124.html Wed, 11 May 2011 14:50:00 -0400 https://ca.proactiveinvestors.com/companies/news/23556/reneuron-welcomes-uk-govt-initiative-to-create-cell-therapy-centre--28124.html ReNeuron confirms it does not use human embryonic stem cells https://ca.proactiveinvestors.com/companies/news/23245/reneuron-confirms-it-does-not-use-human-embryonic-stem-cells--27726.html The company responded to developments in an ongoing European legal case involving a German party. It cited press coverage of a European legal case concerning the patentability of human embryonic stem cells. ReNeuron does not utilise human embryonic stem cells in its own research and development programmes and has no plans to do so.

]]>
Thu, 28 Apr 2011 13:03:00 -0400 https://ca.proactiveinvestors.com/companies/news/23245/reneuron-confirms-it-does-not-use-human-embryonic-stem-cells--27726.html
ReNeuron’s stem cell lines used in groundbreaking anti-depressant research https://ca.proactiveinvestors.com/companies/news/22970/reneurons-stem-cell-lines-used-in-groundbreaking-anti-depressant-research--27393.html Fri, 15 Apr 2011 10:05:00 -0400 https://ca.proactiveinvestors.com/companies/news/22970/reneurons-stem-cell-lines-used-in-groundbreaking-anti-depressant-research--27393.html ReNeuron signs up NHS to manufacture its next generation stem-cells https://ca.proactiveinvestors.com/companies/news/22800/reneuron-signs-up-nhs-to-manufacture-its-next-generation-stem-cells-27187.html Fri, 08 Apr 2011 06:24:00 -0400 https://ca.proactiveinvestors.com/companies/news/22800/reneuron-signs-up-nhs-to-manufacture-its-next-generation-stem-cells-27187.html ReNeuron expects to significantly benefit from UK budget measures https://ca.proactiveinvestors.com/companies/news/22337/reneuron-expects-to-significantly-benefit-from-uk-budget-measures-26654.html Thu, 24 Mar 2011 07:35:00 -0400 https://ca.proactiveinvestors.com/companies/news/22337/reneuron-expects-to-significantly-benefit-from-uk-budget-measures-26654.html Matrix expects ReNeuron to continue reporting positive stem cell trial news https://ca.proactiveinvestors.com/companies/news/21881/matrix-expects-reneuron-to-continue-reporting-positive-stem-cell-trial-news-26097.html Fri, 04 Mar 2011 11:22:00 -0500 https://ca.proactiveinvestors.com/companies/news/21881/matrix-expects-reneuron-to-continue-reporting-positive-stem-cell-trial-news-26097.html ReNeuron to partake in series of UK stem cell and life science conferences https://ca.proactiveinvestors.com/companies/news/21869/reneuron-to-partake-in-series-of-uk-stem-cell-and-life-science-conferences-26085.html Fri, 04 Mar 2011 06:49:00 -0500 https://ca.proactiveinvestors.com/companies/news/21869/reneuron-to-partake-in-series-of-uk-stem-cell-and-life-science-conferences-26085.html ReNeuron’s Hunt says groundbreaking stem-cell trial couldn’t have started any smoother https://ca.proactiveinvestors.com/companies/news/21847/reneurons-hunt-says-groundbreaking-stem-cell-trial-couldnt-have-started-any-smoother-26044.html Thu, 03 Mar 2011 10:07:00 -0500 https://ca.proactiveinvestors.com/companies/news/21847/reneurons-hunt-says-groundbreaking-stem-cell-trial-couldnt-have-started-any-smoother-26044.html ReNeuron settles legal dispute with Neuralstem in the US https://ca.proactiveinvestors.com/companies/news/20997/reneuron-settles-legal-dispute-with-neuralstem-in-the-us-25020.html Fri, 28 Jan 2011 07:50:00 -0500 https://ca.proactiveinvestors.com/companies/news/20997/reneuron-settles-legal-dispute-with-neuralstem-in-the-us-25020.html Matrix ups ReNeuron target price to 33p vs 27p https://ca.proactiveinvestors.com/companies/news/20804/matrix-ups-reneuron-target-price-to-33p-vs-27p-24796.html Thu, 20 Jan 2011 12:55:00 -0500 https://ca.proactiveinvestors.com/companies/news/20804/matrix-ups-reneuron-target-price-to-33p-vs-27p-24796.html ReNeuron reveals Martin Hughes' Toscafund has become a major shareholder https://ca.proactiveinvestors.com/companies/news/20454/reneuron-reveals-martin-hughes-toscafund-has-become-a-major-shareholder-24390.html Fri, 07 Jan 2011 06:47:00 -0500 https://ca.proactiveinvestors.com/companies/news/20454/reneuron-reveals-martin-hughes-toscafund-has-become-a-major-shareholder-24390.html ReNeuron's ReN001 passes safety milestone https://ca.proactiveinvestors.com/companies/news/20258/reneurons-ren001-passes-safety-milestone-24168.html Tue, 21 Dec 2010 06:35:00 -0500 https://ca.proactiveinvestors.com/companies/news/20258/reneurons-ren001-passes-safety-milestone-24168.html ReNeuron addresses funding issue with £10 mln placing https://ca.proactiveinvestors.com/companies/news/20037/reneuron-addresses-funding-issue-with-10-mln-placing--23917.html Stem cell group ReNeuron announced this morning it is raising £10 million from investors. The company will place 181.3 million shares in three separate tranches at a price of 5.5 pence each. That’s a 17 percent discount to the closing price on Friday of 6.6 pence.

 

]]>
Mon, 13 Dec 2010 06:47:00 -0500 https://ca.proactiveinvestors.com/companies/news/20037/reneuron-addresses-funding-issue-with-10-mln-placing--23917.html
ReNeuron reports encouraging data for second stem cell therapy https://ca.proactiveinvestors.com/companies/news/19341/reneuron-reports-encouraging-data-for-second-stem-cell-therapy-23090.html Wed, 17 Nov 2010 07:19:00 -0500 https://ca.proactiveinvestors.com/companies/news/19341/reneuron-reports-encouraging-data-for-second-stem-cell-therapy-23090.html First patient treated with ReNeuron’s stem cell therapy for stroke https://ca.proactiveinvestors.com/companies/news/19313/first-patient-treated-with-reneurons-stem-cell-therapy-for-stroke-23063.html ReNeuron Group this morning announced that it passed another significant milestone – and in the process helped make medical history. The Guildford-based biotechnology group revealed that over the weekend the first patient has been treated with the company’s ReN001 stem cell therapy for strokes as part of a small-scale study.

]]>
Tue, 16 Nov 2010 09:41:00 -0500 https://ca.proactiveinvestors.com/companies/news/19313/first-patient-treated-with-reneurons-stem-cell-therapy-for-stroke-23063.html
ReNeuron investment case boosted by stem cell trial launch in US - Daniel Stewart & Co https://ca.proactiveinvestors.com/companies/news/18371/reneuron-investment-case-boosted-by-stem-cell-trial-launch-in-us-daniel-stewart-co-21976.html Tue, 12 Oct 2010 09:58:00 -0400 https://ca.proactiveinvestors.com/companies/news/18371/reneuron-investment-case-boosted-by-stem-cell-trial-launch-in-us-daniel-stewart-co-21976.html ReNeuron to present at regenerative medicine conference https://ca.proactiveinvestors.com/companies/news/17714/reneuron-to-present-at-regenerative-medicine-conference-21233.html Tue, 21 Sep 2010 10:48:00 -0400 https://ca.proactiveinvestors.com/companies/news/17714/reneuron-to-present-at-regenerative-medicine-conference-21233.html ReNeuron encouraged by progress towards ReN001 stem cell therapy trial https://ca.proactiveinvestors.com/companies/news/17392/reneuron-encouraged-by-progress-towards-ren001-stem-cell-therapy-trial-20856.html Wed, 08 Sep 2010 11:25:00 -0400 https://ca.proactiveinvestors.com/companies/news/17392/reneuron-encouraged-by-progress-towards-ren001-stem-cell-therapy-trial-20856.html ReNeuron's Hunt on the Challenges Facing the Stem Cell Pioneer https://ca.proactiveinvestors.com/companies/news/16963/reneurons-hunt-on-the-challenges-facing-the-stem-cell-pioneer-20382.html ReNeuron's Micheal Hunt talks us through a landmark period for the company and the challenges that lie ahead.

]]>
Tue, 24 Aug 2010 10:07:00 -0400 https://ca.proactiveinvestors.com/companies/news/16963/reneurons-hunt-on-the-challenges-facing-the-stem-cell-pioneer-20382.html
ReNeuron: Michael Hunt CEO discusses Generating value through securing commercial partners https://ca.proactiveinvestors.com/companies/news/300622/reneuron-michael-hunt-ceo-discusses-generating-value-through-securing-commercial-partners-484.html Thu, 29 Jul 2010 10:10:00 -0400 https://ca.proactiveinvestors.com/companies/news/300622/reneuron-michael-hunt-ceo-discusses-generating-value-through-securing-commercial-partners-484.html ReNeuron shares lifted by news of potentially wider application range for CTX stem cell line https://ca.proactiveinvestors.com/companies/news/15460/reneuron-shares-lifted-by-news-of-potentially-wider-application-range-for-ctx-stem-cell-line-18702.html Mon, 12 Jul 2010 09:33:00 -0400 https://ca.proactiveinvestors.com/companies/news/15460/reneuron-shares-lifted-by-news-of-potentially-wider-application-range-for-ctx-stem-cell-line-18702.html ReNeuron Group says it made very substantial progress in FY2010 https://ca.proactiveinvestors.com/companies/news/15063/reneuron-group-says-it-made-very-substantial-progress-in-fy2010-18255.html Tue, 29 Jun 2010 11:43:00 -0400 https://ca.proactiveinvestors.com/companies/news/15063/reneuron-group-says-it-made-very-substantial-progress-in-fy2010-18255.html ReNeuron major shareholder David Royds increases stake https://ca.proactiveinvestors.com/companies/news/12341/reneuron-major-shareholder-david-royds-increases-stake-15157.html Thu, 01 Apr 2010 09:38:00 -0400 https://ca.proactiveinvestors.com/companies/news/12341/reneuron-major-shareholder-david-royds-increases-stake-15157.html ReNeuron makes UK govt’s Best of British publication as regenerative medicine leader https://ca.proactiveinvestors.com/companies/news/11970/reneuron-makes-uk-govts-best-of-british-publication-as-regenerative-medicine-leader-14721.html Mon, 22 Mar 2010 12:33:00 -0400 https://ca.proactiveinvestors.com/companies/news/11970/reneuron-makes-uk-govts-best-of-british-publication-as-regenerative-medicine-leader-14721.html ReNeuron signs two further manufacturing contracts for ReN001 stem cells with Angel Biotech https://ca.proactiveinvestors.com/companies/news/11835/-reneuron-signs-two-further-manufacturing-contracts-for-ren001-stem-cells-with-angel-biotech-14575.html Thu, 18 Mar 2010 09:51:00 -0400 https://ca.proactiveinvestors.com/companies/news/11835/-reneuron-signs-two-further-manufacturing-contracts-for-ren001-stem-cells-with-angel-biotech-14575.html ReNeuron to raise £4.7m in new private placing to advance stem-cell therapies into clinical trials https://ca.proactiveinvestors.com/companies/news/10984/reneuron-to-raise-47m-in-new-private-placing-to-advance-stem-cell-therapies-into-clinical-trials-13602.html Mon, 22 Feb 2010 21:12:00 -0500 https://ca.proactiveinvestors.com/companies/news/10984/reneuron-to-raise-47m-in-new-private-placing-to-advance-stem-cell-therapies-into-clinical-trials-13602.html ReNeuron Secures Financing Into 2011 with new £5 mln equity facility as first half losses narrow https://ca.proactiveinvestors.com/companies/news/8435/reneuron-secures-financing-into-2011-with-new-5-mln-equity-facility-as-first-half-losses-narrow-10643.html Stem cell therapy company ReNeuron (AIM: RENE) secured a £5 million equity funding facility from its loint broker  and reported narrowing losses for the first half.

]]>
Thu, 26 Nov 2009 14:17:00 -0500 https://ca.proactiveinvestors.com/companies/news/8435/reneuron-secures-financing-into-2011-with-new-5-mln-equity-facility-as-first-half-losses-narrow-10643.html
ReNeuron Group presents positive pre-clinical data for CTX stem cell line therapy https://ca.proactiveinvestors.com/companies/news/8035/reneuron-group-presents-positive-pre-clinical-data-for-ctx-stem-cell-line-therapy--10209.html Mon, 16 Nov 2009 10:39:00 -0500 https://ca.proactiveinvestors.com/companies/news/8035/reneuron-group-presents-positive-pre-clinical-data-for-ctx-stem-cell-line-therapy--10209.html Angel Biotech and ReNeuron in manufacturing deal for 2nd generation CTX stem cells https://ca.proactiveinvestors.com/companies/news/6046/angel-biotech-and-reneuron-in-manufacturing-deal-for-2nd-generation-ctx-stem-cells--7993.html Thu, 10 Sep 2009 11:10:00 -0400 https://ca.proactiveinvestors.com/companies/news/6046/angel-biotech-and-reneuron-in-manufacturing-deal-for-2nd-generation-ctx-stem-cells--7993.html ReNeuron publishes data on CTX stem cells showing promise in brain cell regeneration https://ca.proactiveinvestors.com/companies/news/4795/reneuron-publishes-data-on-ctx-stem-cells-showing-promise-in-brain-cell-regeneration-6535.html Wed, 08 Jul 2009 13:18:00 -0400 https://ca.proactiveinvestors.com/companies/news/4795/reneuron-publishes-data-on-ctx-stem-cells-showing-promise-in-brain-cell-regeneration-6535.html ReNeuron’s CTX stem cell line shows promise in pre-clinical data https://ca.proactiveinvestors.com/companies/news/479/reneurons-ctx-stem-cell-line-shows-promise-in-pre-clinical-data-5100.html Mon, 06 Apr 2009 08:14:00 -0400 https://ca.proactiveinvestors.com/companies/news/479/reneurons-ctx-stem-cell-line-shows-promise-in-pre-clinical-data-5100.html ReNeuron to raise up to £3 mln in placing to fund operations for at least 1 year https://ca.proactiveinvestors.com/companies/news/3335/reneuron-to-raise-up-to-3-mln-in-placing-to-fund-operations-for-at-least-1-year-4745.html Thu, 12 Mar 2009 08:41:00 -0400 https://ca.proactiveinvestors.com/companies/news/3335/reneuron-to-raise-up-to-3-mln-in-placing-to-fund-operations-for-at-least-1-year-4745.html ReNeuron – playing its part in the stem cell revolution https://ca.proactiveinvestors.com/companies/news/3237/reneuron-playing-its-part-in-the-stem-cell-revolution-4634.html Wed, 04 Mar 2009 08:00:00 -0500 https://ca.proactiveinvestors.com/companies/news/3237/reneuron-playing-its-part-in-the-stem-cell-revolution-4634.html ReNeuron gets approval for stem cell therapy trial for stroke https://ca.proactiveinvestors.com/companies/news/2771/reneuron-gets-approval-for-stem-cell-therapy-trial-for-stroke-4058.html Mon, 19 Jan 2009 09:31:00 -0500 https://ca.proactiveinvestors.com/companies/news/2771/reneuron-gets-approval-for-stem-cell-therapy-trial-for-stroke-4058.html Reneuron retreats on FDA approval delay https://ca.proactiveinvestors.com/companies/news/1485/reneuron-retreats-on-fda-approval-delay-2212.html
ReNeuron expects it to take several months to supply the additional data required by the FDA. In the meantime, the company plans to accelerate trials in other territories.

Michael Hunt, CEO, said:

"During our meeting with them, the FDA expressed their clear desire to work with us to enable initial clinical studies to commence in the US with ReN001. It is also important to note that the wealth of pre-clinical data we have already generated shows ReN001 to be safe and efficacious, with no adverse safety effects arising. We continue to draw encouragement from these facts, and will continue to work with the FDA to provide the further data they have asked for.

"That said, we now deem it prudent to accelerate the process of filing clinical trial applications for ReN001 in certain other territories where discussions with the relevant regulators have given us high confidence that such applications will be treated favourably. Our principal near-term goal remains to drive the ReN001 programme into its clinical phase in a well-regulated territory at the earliest opportunity. We are confident of achieving that goal over the course of this year."
]]>
Wed, 19 Mar 2008 11:42:00 -0400 https://ca.proactiveinvestors.com/companies/news/1485/reneuron-retreats-on-fda-approval-delay-2212.html
ReNeuron Group says clinical trial on hold https://ca.proactiveinvestors.com/companies/news/446/reneuron-group-says-clinical-trial-on-hold-0754.html

CEO Michael Hunt added "We are encouraged to be able to engage in an immediate dialogue with the FDA regarding our IND application, now that the initial review process has taken place. Given the ground-breaking nature of our ReN001 therapy and the lack of comparable approaches addressing stroke, it is not surprising that the FDA might wish to raise questions or make comments at this point in the approval process. We look forward to a constructive dialogue with the FDA and, in the meantime, we continue with our ongoing preparations for the initial ReN001 clinical study."
]]>
Tue, 09 Jan 2007 10:08:00 -0500 https://ca.proactiveinvestors.com/companies/news/446/reneuron-group-says-clinical-trial-on-hold-0754.html